β-amyloid (1-11) is a fragment of Amyloid-β peptide, maybe used in the research of neurological disease.
β-amyloid 1-11 is a synthetic peptide fragment corresponding to the N-terminal residues 1 through 11 of the amyloid beta (Aβ) protein. As a truncated segment of the full-length Aβ peptide, it serves as a valuable molecular tool in neurobiological and biochemical research, particularly in studies focused on Alzheimer's disease and amyloidogenic processes. Its defined sequence enables researchers to dissect the roles of specific Aβ regions in aggregation, toxicity, and cellular interactions, providing insight into the early molecular events associated with amyloid formation. The availability of such discrete peptide fragments facilitates mechanistic investigations that are otherwise challenging with full-length or heterogeneous amyloid samples.
Peptide aggregation studies: β-amyloid 1-11 is frequently utilized to investigate the initial stages of amyloid aggregation and nucleation. By isolating the N-terminal segment, researchers can examine its intrinsic propensity to form oligomers or interact with other amyloidogenic sequences, shedding light on the sequence-specific determinants that govern aggregation kinetics. These experiments are instrumental in unraveling the early conformational changes that precede plaque formation in neurodegenerative contexts and in distinguishing the contribution of the N-terminal domain from the full-length peptide.
Epitope mapping and antibody development: The defined sequence of this peptide fragment makes it an essential reagent for epitope mapping and the generation of sequence-specific antibodies. Utilizing β-amyloid 1-11 in immunological assays allows researchers to characterize antibody specificity, affinity, and cross-reactivity, which is critical for the development of diagnostic tools and for understanding immune recognition of amyloid species. Such studies also aid in the identification of novel immunogens and the refinement of antibody-based detection methods for amyloid research.
Protein-protein interaction assays: As a model substrate, β-amyloid 1-11 is employed in assays designed to probe interactions between amyloidogenic peptides and cellular or extracellular binding partners. Its use enables the dissection of binding motifs and the identification of molecular chaperones, receptors, or enzymes that selectively recognize the N-terminal region. These interaction studies are foundational for elucidating the molecular pathways implicated in amyloid processing, clearance, or toxicity within neuronal environments.
Peptide modification and structure-function analysis: Researchers leverage this peptide as a template for site-specific modifications, such as phosphorylation, acetylation, or isotopic labeling, to assess their impact on structure and function. By introducing chemical modifications at defined positions, it becomes possible to systematically evaluate how post-translational modifications or sequence alterations influence aggregation behavior, proteolytic stability, or recognition by antibodies and binding proteins. Such structure-function analyses are vital for advancing the understanding of the molecular determinants underlying amyloid biology.
Analytical method development: β-amyloid 1-11 serves as a calibration standard and reference material in various analytical techniques, including mass spectrometry, high-performance liquid chromatography, and capillary electrophoresis. Its well-characterized sequence and physicochemical properties make it suitable for validating assay performance, quantifying peptide concentrations, and optimizing separation protocols. The use of this peptide fragment in method development ensures accuracy and reproducibility in the quantification and detection of amyloid-related peptides in complex biological samples.
3. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
4. TMEM16F and dynamins control expansive plasma membrane reservoirs
5. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More